TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $51,090,221 | +12.1% | 4,318,700 | -43.9% | 1.21% | +17.8% |
| Q3 2022 | $45,595,000 | +59.0% | 7,701,870 | +14.1% | 1.03% | +45.1% |
| Q2 2022 | $28,677,000 | -54.8% | 6,747,549 | +1.0% | 0.71% | -36.6% |
| Q1 2022 | $63,505,000 | -44.6% | 6,677,726 | +10.7% | 1.12% | -13.9% |
| Q4 2021 | $114,663,000 | +4.5% | 6,034,875 | +83.1% | 1.30% | +17.2% |
| Q3 2021 | $109,706,000 | +0.3% | 3,296,451 | +16.9% | 1.11% | +7.6% |
| Q2 2021 | $109,430,000 | -23.6% | 2,821,079 | -5.1% | 1.03% | -22.1% |
| Q1 2021 | $143,209,000 | -14.0% | 2,971,136 | -7.2% | 1.32% | -50.5% |
| Q4 2020 | $166,571,000 | +41.7% | 3,202,061 | -27.1% | 2.67% | +22.1% |
| Q3 2020 | $117,535,000 | +4540.2% | 4,392,196 | +3277.6% | 2.18% | +4022.6% |
| Q2 2020 | $2,533,000 | – | 130,039 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |